bis diammonium phosphate synthesised studied prototype class potential anticancer agents incorporated 125i provides auger electron radiations behave like high let radiations treatment tumours accompanying make undesirable contribution total body dose vitro experiments reported selectively concentrated cells human malignant tumours factor NUMBER NUMBER relation cells normal origin studied basis dosimetric considerations comparison clinical treatment tritiated methylnaphthoquinol diphosphate practical dosage suggested clinical indications safety use discussed types tumour particular inoperable cases carcinoma colon carcinoma pancreas malignant melanoma osteosarcoma investigations progress NUMBER NUMBER iodo NUMBER methyl NUMBER naphthoquinol NUMBER 125i iodo mndp radio halogenated x gamma radiations NUMBER 125i iodo mndp NUMBER 125i iodo mndp